AETHLON MEDICAL, INC. Finite-Lived Patents, Gross
AETHLON MEDICAL, INC. (AEMD) had Finite-Lived Patents, Gross of $157.44 thousand as of 2026-03-31, per its 10-K filed 2026-06-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2026-06-10
- 2026-03-31: Finite-Lived Patents, Gross $157.44K.
- 2025-03-31: Finite-Lived Patents, Gross $157.44K.
- 2024-03-31: Finite-Lived Patents, Gross $157.44K.
- 2023-03-31: Finite-Lived Patents, Gross $157.44K.
| Period end | Finite-Lived Patents, Gross | Finite-Lived Patents, Gross as first filed |
|---|---|---|
| 2026-03-31 | $157.44K 10-K · filed 2026-06-10 | |
| 2025-03-31 | $157.44K 10-K · filed 2026-06-10 | |
| 2024-03-31 | $157.44K 10-K · filed 2025-06-26 | |
| 2023-03-31 | $157.44K 10-K · filed 2024-06-27 | |
| 2022-03-31 | $157.44K 10-K · filed 2023-06-28 | |
| 2021-03-31 | $157.44K 10-K · filed 2022-06-28 | |
| 2020-03-31 | $157.44K 10-K · filed 2021-06-24 | $211.65K 10-K · filed 2020-06-25 |
| 2019-03-31 | $211.65K 10-K · filed 2020-06-25 | |
| 2018-03-31 | $211.65K 10-K · filed 2019-07-01 | |
| 2017-03-31 | $211.65K 10-K · filed 2018-06-08 | |
| 2016-03-31 | $211.65K 10-K · filed 2017-06-28 | |
| 2015-03-31 | $211.65K 10-K · filed 2016-06-29 | $157.44K 10-K · filed 2015-07-13 |
| 2014-03-31 | $157.44K 10-K · filed 2015-07-13 | |
| 2013-03-31 | $157.44K 10-K · filed 2014-07-15 | |
| 2012-03-31 | $157.44K 10-K · filed 2013-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |